Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
Clinical trial NCT03831178 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03831178
- Sponsor
- AHS Cancer Control Alberta
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-28
- Primary completion
- 2024-12-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.